Let's Win Pancreatic Cancer 💜

Let’s Win is your guide to hope and action.

Our mission is to guide pancreatic cancer patients with vital information for better outcomes. 💜

[Let's Win Pancreatic Cancer 💜 @letswinpc]

Pancreatic cancer is most often caught late. On the latest PancChat, Dr. Ray Wadlow breaks down who should be screened, what genetic mutations to know about, and how the @PrecedeStudy is working to change early detection at a global scale.

Listen: https://t.co/NTlzgBWpWe

[Stanford Cancer Institute @StanfordCancer]

Can pancreatic cancer be “cold yet vaccinable”? @TheVinodLab from @MSKCancerCenter shares insights on RNA vaccines at the SCI Breakthroughs in Cancer Series. Watch the full seminar: https://t.co/urhTYigCPX #PancreaticCancer

[Anirban Maitra @Aiims1742]

The preliminary program for @AACR 2026 Special conference on #PancreaticCancer in San Diego is now online. The abstract deadline is July 13th.
#AACRPan26
@PanCAN @letswinpc @lustgartenfdn @break_cancer
https://t.co/GErpStPZ7Q

[Dr. Allyson Ocean @drallysonocean]

.@letswinpc Cracking the KRAS Code
@WeillCornell @WCMGIcancer @nyphospital
https://t.co/KRXJISId8Z

[Emil Lou, MD, PhD, FACP, FASCO @cancerassassin1]

My colleague GI Oncologist Dr. Ajay Prakash @UMNCancer @umnmedschool breaks it down for The @ASCOPost. Published today June 10, 2026:

Daraxonrasib in KRAS-Mutant Pancreatic Cancer: A First Step in Shifting the Paradigm of Treatment
https://t.co/enKbNUGLmP #pancsm

[Let's Win Pancreatic Cancer 💜 @letswinpc]

Dr. Despina Siolas @DrDespina123 is focusing her research on new treatments for pancreatic cancer, particularly ones that go after KRAS mutations. https://t.co/lGXbyi71Y9

[LARVOL @Larvol]

Top trending women GI cancer oncologists on 𝕏 during @ASCO 2026.

Ranked by views of oncologist posts on clinical trials.

Explore more insights and conference data from #ASCO26 👉 https://t.co/7DT5JCwnPG

#LARVOL #ASCO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #ClinicalOncology #GICancer #GastrointestinalCancer #GICSM #ColorectalCancer #GastricCancer #LiverCancer #PancreaticCancer | @GillSharlene | @coffman_kelley | @DraMartinezLago | @NiuSanford | @DrAngelaLamarca | @CathyEngMD | @graokane | @rutikamehtaMD | @rachnatshroff | @drallysonocean

[Brock N. Cordeiro @BNCordeiro]

TODAY is National Cancer Survivors Day.

Please pass House Bill 2432, An Act to reduce incidence and death from pancreatic cancer!

@RonMariano @RepMichlewitz @MassGovernor @maura_healey @MassDems @massgop @PanCANBoston @ACSCANMA @PanCAN @ACSCAN @letswinpc @MAHealthHosp @SeenaMagowitz @NatPancFdn @CarmineLGentile @HannahEKaneMA @Jo_Comerford @BostonGlobe @bostonherald @statehousenews @MASSterList @southcoasttoday @HNNow @WBSM1420 @WSAR1480 @worldpcc @SU2C @worldpancreatic @MassGenBrigham @DanaFarber @umassmemorial @TuftsMedicalCtr @The_BMC @SouthcoastHlth @MedicalHawthorn @BrownUnivHealth @NBC10Boston @wbz @wbznewsradio @WBUR @boston25 @WCVB @7News @FOXProvidence @CoastalABC @NBC10 @wpri12 @markeyforbcda #maleg #mahouse #masen #Cancer #PancreaticCancer #mapoli #magov

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

Pancreatic cancer will look very different in 5 years

✅ KRAS is no longer "undruggable"
✅ Neoantigen vaccines may stop recurrence
✅ AI can identify 'occult' tumors from routine scans

We tackle these stories in our new episode!

#onlyoncologistsinthebuilding

[UA College of Medicine – Tucson @UAZMedTucson]

A potential breakthrough in pancreatic cancer treatment is giving physicians new hope.

“Having treated pancreatic cancer for 16 years, I actually started crying,” said Rachna Shroff, MD, MS. “It’s unprecedented.”
@rachnatshroff

Read more @pbsnewshour: https://t.co/RSptgCYnc7

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

Imagine this:

If CROs and academic centers would allow clinical trials activation and enrollment in the US to be modernized, the KRAS plenary would have been presented in #asco25 and we would have three more RAS trial readouts by today.

[Dr. Anthony Letai @NCIDirector]

We need to better connect discovery to patients’ lived experience. Studies using wearable tech to track sleep in brain tumor patients are a powerful example—bringing real-world data into care and research to improve outcomes. https://t.co/Ms7n2S8fJr

[KRAS Kickers @KRASKickers]

The first shipments of Daraxonrasib have arrived!
-given through the @RevMedicines EAP program
-authorized by the @FDA_Drug_Info
-welcomed by oncologists
-and appreciated by PDAC patients & families

Dr. @steveleeyc knows exactly when to bring his daughter into work for a historic moment!

A KRAS moment that will bring hope (and tears) to patients across the US.

@letswinpc @lustgartenfdn @kevansf @DavidHongMD @GarridoLagunaMD @Aiims1742

[Dr. Shubham Pant @DrShubhamPant]

🙏 Thank you to @AliVelshi and the @MSNOWNews #MSNOW team for having me on to discuss the latest breakthrough in #PancreaticCancer treatment with #Daraxonrasib which received a #StandingOvation at #ASCO26
🫡 #Honored to being a co-investigator and co-author on the abstract and @NEJM manuscript.
..and we’re just getting started 👊👊@PanCAN @DrSamuelBHume @theliverdoc @Aiims1742 @UTMDAnderson @OncBrothers

[A.n.n. @fireflyann]

The segment with @drallysonocean starts at near the 1 hour/10 minute mark

[KRAS Kickers @KRASKickers]

Great #patientFriendly discussion of Daraxonrasib in PDAC @drallysonocean with @katiecouric
On Katie's Substack - starts at 1 hr/12 min - @ASCO plenary, EAP, other cancers & KRAS drugs, prospects for access, the Sasse Rash,

Apparently Katie would love to interview the KRAS OG @kevansf
#LetsGoKatie @letswinpc @SU2C
https://t.co/PIsHKC5PpS

@RevMedicines

[Vincent Rajkumar @VincentRK]

Human scientific ingenuity and hardwork, not AI. Human clinical trialists and patients, not AI

The standing ovation at #ASCO26 for the unprecedented results in metastatic pancreatic cancer with daraxonrasib an oral RAS inhibitor is the result of research excellence and perseverance, and a witness to this.

AI won’t do the work or run the trials to make these advances. It can make the process easier in the future. But you still need human ingenuity and hard works to take a chemical and make it an effective approved medicine.

Institutions and companies must nurture the human talent. Academic medicine is bleeding talent. Leaders are appointed for pliability over excellence. With NIH funding of new investigators at an all time low, coupled with institutions and organizations extolling the efficiencies and prioritizing the virtues of AI, we are at risk slowing down our ability in drug development.

https://t.co/2YRwESyIuu

[Diane M. Simeone, MD @MadameSurgeon]

I joined @SurvivorNetTeam to discuss promising advances in pancreatic cancer research presented at #ASCO26.

The RASolute 302 trial showed daraxonrasib nearly doubled median overall survival compared with chemotherapy in patients with KRAS-mutant pancreatic cancer.

Progress against pancreatic cancer will come from both better treatments and earlier detection. That's why advances like these, and efforts such as @PrecedeStudy, are so important.

https://t.co/7XO6cGzeH4 #PancreaticCancer #KRAS #ASCO26 #PRECEDE

[Allison Fitzgerald, MD, PhD @allisonoconn]

If your main criticism of a new cancer drug that doubles overall survival is “it’s not a cure”, please work on developing intellectually rigorous clinical trial assessments.

And while we’re at it, how about some empathy? An extra YEAR of life is nothing to balk at

[Giovanni Marchegiani @Gio_Marchegiani]

👏 We are all here, in this standing ovation. We are all there, in that Kaplan–Meier curve.

🫶 The hopes of a community. The legacy of those who came before us, and the responsibility entrusted to those who will follow.

Time will tell. But today, we stand here together 💜

[Let's Win Pancreatic Cancer 💜 @letswinpc]

And we have @drallysonocean chatting with @katiecouric about daraxonrasib live on Katie's Substack https://t.co/r6rJ6yhNWd cc @RevMedicines